NC Biomatrix awarded MIT Feasability Grant

NC Biomatrix awarded MIT Feasibility Grant. NC Biomatrix was awarded an MIT Feasibility grant to initiate validation of their injectable biomatrix technology to treat patients with back pain due to disc degeneration. NC Biomatrix CEO Bob Guilleaume commented “We are very grateful for the support by the MIT program. This grant will allow us to begin the validation of commercial manufacturing of our technology, taking the first steps on the path to commercialising this fascinating technology”